Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7000)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2014 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Roeder C, Jordan S, Schulze zur Wiesch J, Pfeiffer-Vornkahl H, Hueppe D, Mauss S, Zehnter E, Stoll S, Alshuth U, Lohse AW, Lueth S. Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection. World J Gastroenterol 2014; 20(31): 10984-10993 [PMID: 25152602 DOI: 10.3748/wjg.v20.i31.10984] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i31/10984.htm |
| Number | Citing Articles |
| 1 |
Adriano M. Pellicelli, Valeria Pace Palitti, Pascal Vignally, Francesca Ceccherini‐Silberstein, Massimo Siciliano, Valerio Giannelli, Alessandra Moretti, Pierluigi Tarquini, Gaetano Scifo, Vincenzo Messina, Antonio Ascione, Antonio Izzi, Massimo Marignani, Cecilia D'Ambrosio, Lucia Fondacaro, Giuseppe M. Ettorre, Pasquale Ialongo, Rodolfo Sacco, Carlo F. Perno, Giorgio Barbarini. Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real‐life study. Liver International 2017; 37(5): 653 doi: 10.1111/liv.13288
|
| 2 |
Feng Su, Lauren A. Beste, Pamela K. Green, Kristin Berry, George N. Ioannou. Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients. European Journal of Gastroenterology & Hepatology 2017; 29(6): 686 doi: 10.1097/MEG.0000000000000858
|
| 3 |
Adriano De Santis, Daniela Maggi, Federica Lubrano Lobianco. Safety and efficacy of directly‐acting antiviral therapy for chronic hepatitis C virus in elderly people. AGING MEDICINE 2021; 4(4): 304 doi: 10.1002/agm2.12190
|
| 4 |
Iria Rodríguez-Osorio, Purificación Cid, Luis Morano, Ángeles Castro, Marta Suárez, Manuel Delgado, Luis Margusino, Héctor Meijide, Berta Pernas, Andrés Tabernilla, José D. Pedreira, Álvaro Mena, Eva Poveda. Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients. Journal of Clinical Virology 2017; 88: 58 doi: 10.1016/j.jcv.2017.01.003
|
| 5 |
Chung-Feng Huang, Ming-Lung Yu. Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments. Expert Opinion on Pharmacotherapy 2017; 18(17): 1867 doi: 10.1080/14656566.2017.1400010
|
| 6 |
Beti Todorovska, Nenad Joksimovic, Viktorija Caloska-Ivanova, Magdalena Dimitrova-Genadieva, Meri Trajkovska, Elena Curakova, Sanja Kiprijanovska, Beti Zafirova-Ivanovska, Vladimir Serafimoski. Factors That Influence the Virological Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin. PRILOZI 2017; 38(1): 25 doi: 10.1515/prilozi-2017-0003
|
| 7 |
Alessandro Federico, Marcello Dallio, Giuseppe Gerardo Caprio, Ilario de Sio, Gaetano Cotticelli, Pasquale Esposito, Carmelina Loguercio. A Real-Life Study of New Antiviral Therapies in a High Prevalence Geographical Area for Hepatitis C Virus Infection. Hepatitis Monthly 2018; (In Press) doi: 10.5812/hepatmon.74224
|
| 8 |
Anca Trifan, Carol Stanciu, Liana Gheorghe, Speranta Iacob, Manuela Curescu, Cristina Cijevschi Prelipcean, Gabriela Stefanescu, Irina Girleanu, Stefan Chiriac, Catalina Mihai, Ciprian Brisc, Adrian Goldis, Ioan Sporea, Egidia Miftode, Simona Bataga, Ion Rogoveanu, Carmen Preda, Florin Alexandru Caruntu, Ana-Maria Singeap. Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older. Medicine 2017; 96(50): e9271 doi: 10.1097/MD.0000000000009271
|
| 9 |
Hsu-Heng Yen, Pei-Yuan Su, I-Ling Liu, Ya-Yuei Zeng, Siou-Ping Huang, Yu-Chun Hsu, Chia-Wei Yang, Yang-Yuan Chen. Direct-acting antiviral treatment for Hepatitis C Virus in geriatric patients: a real-world retrospective comparison between early and late elderly patients. PeerJ 2021; 9: e10944 doi: 10.7717/peerj.10944
|
| 10 |
Mahmoud Elkadeem, Shoman Rabeei Shoman. Treatment of Chronic Hepatitis C Virus Using Direct Acting Antivirals in Geriatric Egyptian Patients. Recent Advances in Anti-Infective Drug Discovery 2021; 16(2): 157 doi: 10.2174/2772434416666210716123909
|
| 11 |
Sammy Saab, Justin Rheem, Vinay Sundaram. Hepatitis C Infection in the Elderly. Digestive Diseases and Sciences 2015; 60(11): 3170 doi: 10.1007/s10620-015-3717-6
|
| 12 |
F. Conti, S. Brillanti, F. Buonfiglioli, R. Vukotic, M. C. Morelli, C. Lalanne, M. Massari, F. G. Foschi, V. Bernabucci, I. Serio, G. M. Prati, E. Negri, L. Badia, P. Caraceni, P. Muratori, G. Vitale, A. Porro, M. Morotti, G. Mazzella, P. Andreone. Safety and efficacy of direct‐acting antivirals for the treatment of chronic hepatitis C in a real‐world population aged 65 years and older. Journal of Viral Hepatitis 2017; 24(6): 454 doi: 10.1111/jvh.12663
|
| 13 |
Calvin Q. Pan, Vijay Gayam, Charles Rabinovich, Milana Normatov, Bazhena Fidman, Dan Wang, Pavani Garlapati. Efficacy of Direct‐Acting Antivirals for Chronic Hepatitis C in a Large Cohort of Older Adults in the United States. Journal of the American Geriatrics Society 2020; 68(2): 379 doi: 10.1111/jgs.16206
|
| 14 |
Ismaeel A Alshoaibi, Abdullah Al-Gamli, Mohammed Abdullah, Basheer Abdo, Khaled H Alzanen, Mohammed Alhakamy, Mamoon Al-Namer, Faisal Ahmed, Munther Tamesh , Wadhah Mahdi , Zeyad Abdo, Marwa Mohammed . Effectiveness of Ledipasvir-Sofosbuvir 12 Weeks After Hepatitis C Virus Genotype 1 Infection and the Factors Associated With Sustained Virologic Response: A Retrospective Study. Cureus 2024; doi: 10.7759/cureus.68249
|
| 15 |
Sammy Saab, Sarah H. Park, Masashi Mizokami, Masao Omata, Alessandra Mangia, Ed Eggleton, Yanni Zhu, Steven J. Knox, Phil Pang, Mani Subramanian, Kris Kowdley, Nezam H. Afdhal. Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older. Hepatology 2016; 63(4): 1112 doi: 10.1002/hep.28425
|
| 16 |
Yee Tak Hui, Grace L. H. Wong, James Y. Y. Fung, Henry L. Y. Chan, Nancy W. Y. Leung, Sienna D. Liu, Ken Liu, Yiu Keung Ma, David Y. K. But, Wing Yan Mak, Jacky M. C. Chan, Kin Bon Lai, Ching Kong Loo, Annie C. Y. Ng, Moon Sing Lai, Chun Wing Chan, Joulen Y. L. Lau, Tina T. T. Fan, Aric J. Hui, Belsy C. Y. Lam, Wing I. Cheung, Owen T. Y. Tsang, Karen Lam, Lawrence S. W. Lai, Wai Fan Luk, Michael K. K. Li, Wai Cheung Lao, Jodis T. W. Lam, Steven W. C. Tsang, Kam Ngai Kung, Wai Hung Chow, Ronald K. N. Tong, Thomas K. L. Lui, Edwin H. S. Shan, Man Fung Yuen, Vincent W. S. Wong. Territory‐wide population‐based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong Kong. Liver International 2018; 38(11): 1911 doi: 10.1111/liv.13926
|
| 17 |
Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Noritomo Shimada, Hiroshi Abe, Keizo Kato, Tomomi Okubo, Taeang Arai, Norio Itokawa, Etsuko Iio, Yasuhito Tanaka, Katsuhiko Iwakiri. Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis C. Digestive and Liver Disease 2017; 49(9): 1029 doi: 10.1016/j.dld.2017.04.012
|
| 18 |
Rowena E. Johnston, Mary M. Heitzeg. Sex, Age, Race and Intervention Type in Clinical Studies of HIV Cure: A Systematic Review. AIDS Research and Human Retroviruses 2015; 31(1): 85 doi: 10.1089/aid.2014.0205
|